Tvardi Therapeutics, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0 | 0 | 0 | 0 | 2.6M | 0 | 0 | 0 |
| Cost of Goods Sold | 0 | 0 | 0 | 47K | 0 | 0 | 0 | 5K |
| Gross Profit | 0 | 0 | 0 | -47K | 2.6M | 0 | 0 | -5K |
| R&D Expenses | 4.9M | 5.5M | 3.6M | 5.8M | 319K | 8.6M | 4.8M | 6.5M |
| Operating Expenses | 7.1M | 7.6M | 5.9M | 8.8M | 5.0M | 10.8M | 5.7M | 7.2M |
| Operating Income | -7.1M | -7.6M | -5.9M | -8.9M | -2.4M | -10.8M | -5.7M | -7.2M |
| Other Income / Gains | 247K | 312K | 411K | 13.0M | -2.5M | -1.9M | 163K | 206K |
| Net Income | -6.8M | -7.3M | -5.5M | 4.2M | -4.9M | -12.7M | -5.5M | -7.0M |
| EPS (Diluted) | -0.73 | -0.78 | -0.59 | 0.51 | -0.52 | -5.04 | -8.19 | -13.17 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0 | 0 | 0 | 0 | 1.00 | 0 | 0 | 0 |
| General And Administrative Expenses | 2.1M | 2.0M | 2.3M | 3.1M | 4.6M | 2.1M | 838K | 0 |
| Selling And Marketing Expenses | 46K | 46K | 45K | 0 | 0 | 50K | 43K | 0 |
| Selling General And Administrative Expenses | 2.1M | 2.1M | 2.3M | 3.1M | 4.6M | 2.2M | 881K | 645K |
| Other Expenses | 0 | 0 | 0 | -47K | 0 | 0 | 0 | 0 |
| Cost And Expenses | 7.1M | 7.6M | 5.9M | 8.9M | 5.0M | 10.8M | 5.7M | 7.2M |
| Interest Income | 247K | 312K | 411K | 377K | 0 | 421K | 766K | 206K |
| Interest Expense | 0 | 0 | 0 | 0 | 2.9M | 2.6M | 2.0M | 1.9M |
| Depreciation And Amortization | 0 | 24K | 24K | 47K | 24K | 24K | 24K | 5K |
| Ebitda | -6.8M | -7.3M | -5.5M | 4.2M | -2.0M | -10.1M | -3.5M | -7.0M |
| Ebitdaratio | 0 | 0 | 0 | 0 | -0.784 | 0 | 0 | 0 |
| Operating Income Ratio | 0 | 0 | 0 | 0 | -0.929 | 0 | 0 | 0 |
| Income Before Tax | -6.8M | -7.3M | -5.5M | 4.2M | -4.9M | -12.7M | -5.5M | -7.0M |
| Income Before Tax Ratio | 0 | 0 | 0 | 0 | -1.91 | 0 | 0 | 0 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income Ratio | 0 | 0 | 0 | 0 | -1.91 | 0 | 0 | 0 |
| Epsdiluted | -0.73 | -0.78 | -0.59 | -1.00 | -0.52 | -5.04 | -8.19 | -13.17 |
| Weighted Average Shs Out | 9.4M | 9.3M | 9.4M | 8.2M | 9.4M | 1.5M | 1.5M | 1.5M |
| Weighted Average Shs Out Dil | 9.4M | 9.4M | 9.4M | 8.5M | 9.4M | 1.5M | 1.5M | 1.5M |